According to a new report from Intel Market Research, the global Antisense Oligonucleotides for Cancer Treatment market was valued at USD 1,826 million in 2024 and is projected to reach USD 4,329 million by 2032, growing at an impressive CAGR of 13.3% during the forecast period (2025-2032). This significant growth trajectory reflects increasing clinical adoption of ASO-based therapies, rapid advances in precision oncology, and the urgent need for innovative cancer treatments.
Read MoreAccording to a new report from Intel Market Research, the global robot sensor market was valued at USD 867 million in 2024 and is projected to grow from USD 934 million in 2025 to USD 1,344 million by 2032, exhibiting a CAGR of 7.5% during the forecast period (2025–2032). This substantial growth is propelled by accelerating industrial automation, advancements in artificial intelligence and machine learning integration, and the expanding deployment of collaborative robots across diverse sectors.
Read MoreAccording to a new report from Intel Market Research, the global chiral HPLC column market was valued at USD 93.4 million in 2024 and is projected to grow from USD 98.6 million in 2025 to USD 139 million by 2032, exhibiting a CAGR of 6.0% during the forecast period (2025–2032). This steady growth reflects the critical role of chiral separations in pharmaceutical quality control and drug development.
Read MoreAccording to a new report from Intel Market Research, the global sulfosuccinate market was valued at USD 436 million in 2024 and is projected to reach USD 524 million by 2032, at a compound annual growth rate (CAGR) of 2.7% during the forecast period (2025–2032). This consistent expansion is driven by the robust demand from the personal care and cosmetics industry, where sulfosuccinates are prized as mild, high-foaming surfactants essential for sensitive-skin formulations.
Read MoreConsultants design and manage scalable Azure cloud solutions, improving security, automation, and reliability for stronger digital operations.
Read More